FMP
Infinity Pharmaceuticals, Inc.
INFI
NASDAQ
Inactive Equity
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the treatment of solid tumors. The company has strategic alliances with Intellikine, Inc. to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K; Verastem, Inc. to research, develop, commercialize, and manufacture duvelisib and products containing duvelisib; and PellePharm, Inc. to develop and commercialize rights to its hedgehog inhibitor program, IPI-926, a clinical-stage product candidate, as well as collaboration agreements with Arcus Biosciences, Inc., F. Hoffmann-La Roche Ltd., and Bristol Myers Squibb Company. Infinity Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in Cambridge, Massachusetts.
0.008 USD
-0.0088 (-110%)
Earnings
Dividends
We are unable to load the chart at this time.
Splits
From:
To:
Date
Revenue
Earnings
Estimated Earnings
Surprise
2024-08-08
0
0
0
-
2024-05-07
0
0
0
-
2024-03-26
0
0
0
-
2023-11-13
0
0
0
-
2023-08-08
583k
-0.11
-0.12
-8.33%
2023-05-09
731k
-0.12
-0.11
9.09%
2022-12-31
543k
-0.1
0
-
2022-11-14
712k
-0.12
-0.05
140.00%
2022-08-09
686k
-0.13
-0.14
-7.14%
2022-05-03
652k
-0.14
-0.14
0.00%
2021-12-31
451k
-0.13
0
-
2021-11-02
428k
-0.12
-0.14
-14.29%
2021-07-27
512k
-0.13
-0.13
0.00%
2021-05-13
467k
-0.15
-0.14
7.14%
2021-03-16
436k
-0.17
-0.16
6.25%
2020-11-09
496k
-0.16
-0.15
6.67%
2020-07-30
360k
-0.16
-0.2
-20.00%
2020-05-11
428k
-0.19
-0.09
111.11%
2020-03-03
308k
-0.2
-0.19
5.26%
2019-10-30
343k
-0.2
-0.18
11.11%
2019-07-30
257k
-0.18
-0.15
20.00%
2019-05-07
2.14M
-0.24
-0.05
380.00%
2019-03-14
146k
-0.14
-0.17
-17.65%
2018-11-05
22M
0.23
-0.15
-253.33%
2018-08-07
0
-0.12
-0.2
-40.00%
2018-05-08
0
-0.18
-0.18
0.00%
2018-03-15
0
-0.14
-0.27
-48.15%
2017-11-07
6M
-0.14
-0.21
-33.33%
2017-08-03
0
-0.34
-0.22
54.55%
2017-05-09
0
-0.21
-0.22
-4.55%
2017-03-14
0
-0.46
-0.57
-19.30%
2016-11-09
0
-0.39
-0.84
-53.57%
2016-08-09
9.47M
-0.43
-0.89
-51.69%
2016-05-04
9.26M
-0.82
-0.86
-4.65%
2016-02-23
9.08M
-0.8
-0.83
-3.61%
2015-11-05
90.74M
0.84
-0.55
-252.73%
2015-08-06
4.88M
-0.78
-0.98
-20.41%
2015-05-06
4.36M
-1.91
-1.54
24.03%
2015-02-24
4.36M
-0.83
-0.99
-16.16%
2014-11-06
160.64M
2.03
-0.86
-336.05%
2014-08-05
0
-0.78
-0.82
-4.88%
2014-05-06
0
-0.87
-0.8
8.75%
2014-02-25
0
-0.68
-0.83
-18.07%
2013-11-07
0
-0.71
-0.74
-4.05%
2013-08-08
0
-0.68
-0.62
9.68%
2013-05-07
0
-0.57
-0.67
-14.93%
2013-03-05
0
-1.15
-0.89
29.21%
2012-11-06
0
-0.8
-0.67
19.40%
2012-08-07
21.91M
-0.54
-0.38
42.11%
2012-05-08
25.2M
-0.4
-0.37
8.11%
2012-03-13
22.32M
-0.53
-0.42
26.19%
2011-11-08
23.3M
-0.45
-0.42
7.14%
2011-08-09
19.96M
-0.44
-0.36
22.22%
2011-05-10
27.19M
-0.09
-0.36
-75.00%
2011-03-15
14.76M
-0.53
-0.39
35.90%
2010-11-09
22.19M
-0.81
-0.76
6.58%
2010-08-04
18.39M
-0.24
-0.32
-25.00%
2010-05-06
15.99M
-0.32
-0.34
-5.88%
